Prevalence of Anxiety and Depressive Disorders in a Sample of Moscow Residents: Comparison of the GAD-7 and HADS Results with a Clinical Assessment

Valeriya I. Savenkova , Yana A. Zorkina , Alexandra G. Ochneva , Angelina I. Zeltzer , Darya A. Ryabinina , Anna M. Tsurina , Elizaveta A. Golubeva , Anna S. Goncharova , Irina V. Alekseenko , George P. Kostyuk , Anna Yu. Morozova

Consortium PSYCHIATRICUM ›› 2024, Vol. 5 ›› Issue (4) : 5 -15.

PDF (308KB)
Consortium PSYCHIATRICUM ›› 2024, Vol. 5 ›› Issue (4) :5 -15. DOI: 10.17816/CP15487
RESEARCH
research-article

Prevalence of Anxiety and Depressive Disorders in a Sample of Moscow Residents: Comparison of the GAD-7 and HADS Results with a Clinical Assessment

Author information +
History +
PDF (308KB)

Abstract

BACKGROUND: Anxiety and depressive disorders are the most common mental disorders. Detecting a disorder at an early stage can prevent the development of severe disorders and preserve the patient’s functioning ability. Simple and reliable screening tools based on self-completion of questionnaires can be used for this purpose. However, it is not always the case that the scores of the self-questionnaire align with those of the clinician.

AIM: To estimate the prevalence of anxiety-depressive disorders using the GAD-7 and HADS self-report questionnaires compared to psychiatrist assessment.

METHODS: The study included individuals aged 18 to 65 years, living in Moscow, Russia, without psychiatric disorders, who participated in an online study using the HADS (Hospital Anxiety and Depression Scale, HADS-A and HADS-D) and GAD-7 (Generalized Anxiety Disorder 7-item scale). Anxiety disorder was diagnosed when the total score was ≥10 on the GAD-7 and/or ≥10 on the HADS-A scale, and depression was defined when the total score was ≥9 on the HADS-D scale. Then, 82 randomly selected participants attended an anonymous consultation with a psychiatrist.

RESULTS: The study included 1,097 individuals (72% female), median age 29 (23; 37) years. As a result of testing, anxiety disorder was found in 168 (15%); depressive disorder — in 152 (14%) respondents. At medical verification, anxiety was diagnosed in 18 (22%); depression — in 19 (23%) people. The sensitivity of the HADS-D subscale for physician-diagnosed cases of depression was 61%, and specificity was 73%. The sensitivity of the HADS-A and GTR-7 subscale in identifying cases of anxiety disorder was 58%, specificity 59%. Sixteen percent were first diagnosed with a personality disorder or schizotypal disorder.

CONCLUSION: The level of anxiety and depression in our sample of the population of Moscow, Russia, was higher than the global level. Self-assessment based on the questionnaire seems to not fully reflect the real state of a patient, as evidenced by the differences with the psychiatrist’s assessment.

Keywords

depression / anxiety / urban population / GAD-7 / HADS

Cite this article

Download citation ▾
Valeriya I. Savenkova, Yana A. Zorkina, Alexandra G. Ochneva, Angelina I. Zeltzer, Darya A. Ryabinina, Anna M. Tsurina, Elizaveta A. Golubeva, Anna S. Goncharova, Irina V. Alekseenko, George P. Kostyuk, Anna Yu. Morozova. Prevalence of Anxiety and Depressive Disorders in a Sample of Moscow Residents: Comparison of the GAD-7 and HADS Results with a Clinical Assessment. Consortium PSYCHIATRICUM, 2024, 5(4): 5-15 DOI:10.17816/CP15487

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9

[2]

Javaid SF, Hashim IJ, Hashim MJ, et al. Epidemiology of anxiety disorders: global burden and sociodemographic associations. Middle East Current Psychiatry. 2023;30(1):44. doi: 10.1186/s43045-023-00315-3

[3]

Korabel’nikova EA. [Anxiety disorders in adolescents]. Medicinskij sovet. 2018;(18):34-43. In Russian. doi: 10.21518/2079-701X-2018-18-34-43

[4]

Evstifeeva SE, Shal’nova SA, Kucenko VA, et al. [Anxiety and depression: ten-year changes of prevalence and its association with demographic and socio-economic characteristics according to the ESSE-RF study]. Kardiovaskuljarnaja terapija i profilaktika. 2023;22(S8):68-79. In Russian. doi: 10.15829/1728-8800-2023-3796

[5]

Soljanik MA. [Depression in general medical practice: an educational and methodological guide]. Saint-Petersburg: Publishing house of the I. I. Mechnikov NWSMU; 2015. 41 p. In Russian.

[6]

Nair SS, Kwan SC, Ng CWM, et al. Approach to the patient with multiple somatic symptoms. Singapore Med J. 2021;62(5):252-258. doi: 10.11622/smedj.2021059

[7]

Barry MJ, Nicholson WK, Silverstein M, et al. Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(23):2057-2067. doi: 10.1001/jama.2023.9297

[8]

Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77. doi: 10.1016/s0022-3999(01)00296-3

[9]

Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. doi: 10.1001/archinte.166.10.1092

[10]

Annunziata MA, Muzzatti B, Bidoli E, et al. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support Care Cancer. 2020;28(8):3921-3926. doi: 10.1007/s00520-019-05244-8

[11]

Pogosova NV, Oganov RG, Bojcov SA, et al. [Psychosocial factors and life quality in coronary heart disease patients: results of the russian part of international multicenter study EUROASPIRE IV]. Kardiovaskuljarnaja terapija i profilaktika. 2017;16(5):20-26. In Russian. doi: 10.15829/1728-8800-2017-5-20-26

[12]

Klinkova AS, Kamenskaja OV, Loginova IJu, et al. [Features of psychoemotional status in patients with chronic thromboembolic pulmonary hypertension after cardiac surgery during the COVID-19 pandemic]. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2022;122(8):80-87. In Russian. doi: 10.17116/jnevro202212208180

[13]

Huang XJ, Ma HY, Wang XM, et al. Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder. J Affect Disord. 2022;311:327-335. doi: 10.1016/j.jad.2022.05.079

[14]

Snijkers JTW, van den Oever W, Weerts ZZRM, et al. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome. Neurogastroenterol Motil. 2021;33(12):e14161. doi: 10.1111/nmo.14161

[15]

Zolotareva AA. [Adaptation of the Russian version of the Generalized Anxiety Disorder-7]. Konsul’tativnaya psikhologiya i psikhoterapiya. 2023;31(4):31-46. In Russian. doi: 10.17759/cpp.2023310402

[16]

Morozova MA, Potanin SS, Beniashvili AG, et al. [Validation of the Hospital Anxiety and Depression Scale Russian-language version in the general population]. Profilakticheskaja medicina. 2023;26(4):7-14. In Russian. doi: 10.17116/profmed2023260417

[17]

Muzzatti B, Agostinelli G, Bomben F, et al. Intensity and Prevalence of Psychological Distress in Cancer Inpatients: Cross-Sectional Study Using New Case-Finding Criteria for the Hospital Anxiety and Depression Scale. Front Psychol. 2022;13:875410. doi: 10.3389/fpsyg.2022.875410

[18]

Soares-Filho GL, Freire RC, Biancha K, et al. Use of the hospital anxiety and depression scale (HADS) in a cardiac emergency room: chest pain unit. Clinics (Sao Paulo). 2009;64(3):209-214. doi: 10.1590/s1807-59322009000300011

[19]

Karpenko OA, Melihov OG, Tjazhel’nikov AA, et al. [Diagnosing and treating depression and anxiety in patients with cardiovascular disorders and diabetes mellitus in primary healthcare: is training of physicians enough for improvement]? Consortium Psychiatricum. 2021;2(4):2-12. In Russian. doi: 10.17816/CP112

[20]

Hu Z, Li M, Yao L, et al. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC gastroenterol. 2021;21(1):23. doi: 10.1186/s12876-020-01593-5

[21]

Syunyakov T, Zorkina Y, Ochneva A, et al. Comparison of Anxiety and Depression Rates in Russian Health Care Professionals in 2020 and 2023. Psychiatr Danub. 2023;35(Suppl 2):296-301.

[22]

Morys JM, Bellwon J, Adamczyk K, et al. Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument. Kardiol Pol. 2016;74(1):53-60. doi: 10.5603/KP.a2015.0116

[23]

Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. doi: 10.1001/archinte.166.10.1092

[24]

[The GTR-7 questionnaire (GAD7) and the WFSBP recommendations for the treatment of generalized anxiety disorder]. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Behtereva. 2013;(2):71. In Russian.

[25]

Wu Y, Levis B, Sun Y, et al. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021;373:n972. doi: 10.1136/bmj.n972

[26]

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. doi: 10.1111/j.1600-0447.1983.tb09716.x

[27]

Kukshina AA, Kotel’nikova AV, Rassulova MA, et al. [Investigation of the psychometric properties of the hospital anxiety and depression scale (HADS) recommended for general medical practitioners, on a sample of patients with impaired motor functions]. Klinicheskaja i special’naja psihologija. 2023;12(2):1-24. In Russian. doi: 10.17759/cpse.2023120201

[28]

Karpenko OA, Syunyakov TS, Kulygina MA, et al. Impact of COVID-19 pandemic on anxiety, depression and distress-online survey results amid the pandemic in Russia. Consort Psychiatr. 2020;1(1):8-20. doi: 10.17650/2712-7672-2020-1-1-8-20

[29]

Andreescu C, Varon D. New research on anxiety disorders in the elderly and an update on evidence-based treatments. Curr Psychiatry Rep. 2015;17(7):53. doi: 10.1007/s11920-015-0595-8

[30]

Caldwell DM, Davies SR, Hetrick SE, et al. School-based interventions to prevent anxiety and depression in children and young people: a systematic review and network meta-analysis. Lancet Psychiatry. 2019;6(12):1011-1020. doi: 10.1016/S2215-0366(19)30403-1

[31]

Lakasing E, Mirza Z. Anxiety and depression in young adults and adolescents. Br J Gen Pract. 2020;70(691):56-57. doi: 10.3399/bjgp20X707765

[32]

Sato H, Kawahara J. Selective bias in retrospective self-reports of negative mood states. Anxiety Stress Coping. 2011;24(4):359-367. doi: 10.1080/10615806.2010.543132

[33]

Howren MB, Suls J. The symptom perception hypothesis revised: depression and anxiety play different roles in concurrent and retrospective physical symptom reporting. J Pers Soc Psychol. 2011;100(1):182-195. doi: 10.1037/a0021715

[34]

Taple BJ, Griffith JW, Wolf MS. Interview Administration of PROMIS Depression and Anxiety Short Forms. Health Lit Res Pract. 2019;3(3):e196-e204. doi: 10.3928/24748307-20190626-01

[35]

Wang B, Nemesure MD, Park C, et al. Leveraging deep learning models to understand the daily experience of anxiety in teenagers over the course of a year. J Affect Disord. 2023;329:293-299. doi: 10.1016/j.jad.2023.02.084

[36]

Winsper C, Bilgin A, Thompson A, et al. The prevalence of personality disorders in the community: a global systematic review and metaanalysis. Br J Psychiatry. 2020;216(2):69-78. doi: 10.1192/bjp.2019.166

[37]

Lindhardt L, Nilsson LS, Munk-J0rgensen P, et al. Unrecognized schizophrenia spectrum and other mental disorders in youth disconnected from education and work-life. Front Psychiatry. 2022;13:1015616. doi: 10.3389/fpsyt.2022.1015616

[38]

Ruzhenkova VV, Ruzhenkov VA. [The problem of stigma in psychiatry and suicidology]. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Serija: Medicina. Farmacija. 2012;(4):5-13. In Russian.

[39]

Vertogradova OP, Stepanov IL, Maksimova NM, et al. [Clinical and pathogenetic aspects in typology of depression]. Social’naja i klinicheskaja psihiatrija. 2012;22(3):5-10. In Russian.

[40]

Petrova NN, Palkin JuP, Faddeev DV, et al. [Comorbidity of depression and anxiety in clinical practice]. Zhurnal nevrologii i psihiatrii im. C. C Korsakova. 2021;121(4):31-37. In Russian. doi: 10.17116/jnevro202112104131

[41]

Ionescu DF, Niciu MJ, Henter ID, et al. Defining anxious depression: a review of the literature. CNS Spectr. 2013;18(5):252-260. doi: 10.1017/S1092852913000114

[42]

Reed GM, Sharan P, Rebello TJ, et al. The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders: results among adult patients in mental health settings of 13 countries. World Psychiatry. 2018;17(2):174-186. doi: 10.1002/wps.20524

[43]

Fatima SM, Khan S, Sadia R. The Relationship between Perceived Infectability and Psychological Well-being: The Mediating Role of Covid-19 Anxiety. Psychol Russ. 2023;16(2):63-71. doi: 10.11621/pir.2023.0205

[44]

Klimochkina AY, Nekhorosheva EV, Kasatkina DA. Existential Well-being, Mental Health, and COVID-19: Reconsidering the Impact of Lockdown Stressors in Moscow. Psychol Russ. 2022;15(2):14-31. doi: 10.11621/pir.2022.0202

RIGHTS & PERMISSIONS

Savenkova V.I., Zorkina Y.A., Ochneva A.G., Zeltzer A.I., Ryabinina D.A., Tsurina A.M., Golubeva E.A., Goncharova A.S., Alekseenko I.V., Kostyuk G.P., Morozova A.Y.

AI Summary AI Mindmap
PDF (308KB)

52

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/